Just Answers
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > Blockbuster Needs a Change of View

Tags

  • newswire
  • drugs
  • their online
  • combination products
  • companies involved

  • Links

  • Cho Seung-Hui Tattoo Interpretation - Paradoxical and Prophetic
  • Mirror, Mirror in Feng Shui
  • Network Marketing. The Truth, The Whole Truth, And Nothing... BUT?
  • Just Answers - Blockbuster Needs a Change of View

    The Dallas, Texas based video rental giant Blockbuster Inc (NYSE: BBI) has been under tremendous pressure over the past few years. From being one of the most sought after public companies on Wall Street to being reduced to a f
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    our-dollar stock. The company has seen better days, but at this point we need to take a look at the possibilities that can arise from the company being backed into a corner.

    Back in March we pretty much saw Blockbuster in a d
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    rk place but there may be a silver lining there. Carl Icahn is a savvy businessman and even though Blockbuster is being sued by Netflix (NASDAQ: NFLX) for patent infringement of their online DVD rental business, there still ma
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    be a rabbit in his hat.

    The company has already stated that they will be looking to eliminate some of the non-performing stores and by doing this it will eliminate those loses and actually have a positive effect on their bal
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ance sheet.

    If Blockbuster takes the necessary steps to restructure the company properly it may be in a position to possibly seek acquisitions for additional growth. Some possible acquisition candidates or strategic alliance
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    artners may include Netflix and Movie Gallery (NASDAQ: MOVI). Working a deal out with Netflix eliminates the lawsuit and will allow Blockbuster to reap the rewards that are present in Internet sales, while a deal with Movie Ga
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    lery would give them additional locations in areas that they do not have a heavy presence in.

    So the key component for Blockbuster that we see is the expansion of their online DVD rental business, which they may be in line to
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    do. So Blockbuster trading at $4.81 may be a memory as they company redefines itself in 2006.

    Blockbuster closed at $4.89 on Wednesday.

    Click here for your free subscription to Wall Street to Main Street from the NAMC Newsw
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    re, delivered to investors daily. www.namcnewswire.com

    Louis Victor NAMC Newswire www.namcnewswire.com

    This article can be republished either online or in print as long as credit is given to the author and the NAMC Newswi
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    e.

    NAMC Newswire articles can now be listened to on StreetIQ.com http://www.streetiq.com/dir/NAMC.shtml

    To keep up to date with companies that we report on just register to receive the FREE Wall Street to Main Street Daily
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ewsletter. We feature companies that trade on the NYSE, AMEX, NASDAQ, OTCBB and Overseas, Keeping our readers informed daily. Just go to our site and register, it’s simple and free, www.namcnewswire.com/newsletter . Also be su
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    re to visit the NAMC radio at www.namcnewswire.com/namcradio for the latest reports, interviews and corporate updates featured on the NAMC Newswire.

    Disclaimer:

    None of the information contained on the NAMC Newswire constitu
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    es a recommendation by the NAMC Newswire, its journalist, nor its parent company that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific investors or person. Each
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    individual investor must make their own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy featured on the NAMC Newswire or NAMC Radio Any past results are not necessaril
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    y indicative of future performance. The NAMC Newswire, its journalist nor its parent company does not guarantee any specific outcome or profit, and all investors should be aware of the real risk of loss in following any strate
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    y or investments featured on the NAMC Newswire or the NAMC Radio. The strategy or investments discussed may fluctuate in price or value and investors may get back less than you invested. Before acting on any information featur
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    d on the NAMC Newswire website or the NAMC Radio segment, investors should consider whether it is suitable for their particular circumstances and strongly consider seeking advice from their own financial or investment adviser.
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    Investors are also urged to do their own due diligence before investing in any security.

    All opinions featured on the NAMC Newswire or NAMC Radio are based upon information that is considered to be reliable, but neither the
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    AMC Newswire, its journalist, its parent company, affiliates nor assigns warrant its completeness or accuracy, and it should not be relied upon as such. The statements and opinions featured on the NAMC Newswire by its journali
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    t are based on their outlook at the time of the statement or opinion, and are subject to change without notice. NAMC may at times hold a position in the companies that it features, in these cases appropriate disclosure is made


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justanswers.org.ua/article/103750/justanswers-Blockbuster-Needs-a-Change-of-View.html">Blockbuster Needs a Change of View</a>

    BB link (for phorums):
    [url=http://www.justanswers.org.ua/article/103750/justanswers-Blockbuster-Needs-a-Change-of-View.html]Blockbuster Needs a Change of View[/url]

    Related Articles:

    Ten Things You Should Focus on to Transform Your Finance Function

    Marketing in the Face of Disaster: 7 Guidelines for Success

    The Formula For Online Business Success

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com